Ionis Pharmaceuticals Quarterly Cash Flow Statement
NASDAQ: IONSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ionis Pharmaceuticals free cash flow
In the quarter ended Jun 30, 2026, Ionis Pharmaceuticals generated $565.5 million of operating cash flow and spent $16.1 million on capital expenditures. That left free cash flow of $549.5 million, a free-cash-flow margin of 205.1% of revenue. Free cash flow was up 295.2% from the prior year's $139.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Ionis Pharmaceuticals cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q2 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -114.65M | -92.53M | -229.39M | -128.61M | 123.55M | -146.94M | -104.35M | -140.48M | -66.27M | -142.80M | -9.26M | -147.41M |
| Net Income growth (YoY) | -192.79% | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 3.43M | 3.30M | 3.26M | 2.25M | 2.27M | 2.23M | 2.24M | 2.36M | 2.47M | 2.55M | 2.54M | 2.52M |
| Stock-Based Compensation | 45.59M | 43.27M | 43.32M | 31.15M | 29.69M | 29.72M | 36.15M | 31.98M | 30.73M | 31.34M | 26.34M | 25.96M |
| Change in Working Capital | -42.24M | -30.96M | 85.83M | -128.01M | -38.76M | -51.04M | -1.84M | -33.63M | -101.08M | -35.21M | -55.51M | 86.74M |
| Operating Cash Flow | 565.53M | -792.82M | -137.71M | -131.44M | 151.34M | -150.78M | -116.14M | -114.99M | -119.88M | -149.94M | 32.87M | -109.02M |
| Capital Expenditures | -16.08M | -21.76M | -21.29M | -5.27M | -12.30M | -12.58M | -25.50M | -9.06M | -6.23M | -4.49M | 819.00K | -2.14M |
| Investing Cash Flow | 23.50M | 536.82M | -419.50M | 91.34M | -120.07M | 170.46M | 68.21M | -340.80M | 62.45M | 76.11M | -26.71M | 68.71M |
| Financing Cash Flow | -412.29M | 57.26M | 591.18M | 81.22M | 1.25M | 2.20M | -44.12M | 496.05M | 2.56M | 23.57M | 40.72M | -32.27M |
| Net Change in Cash | 176.68M | -198.88M | 33.92M | 41.04M | 33.11M | 22.11M | -92.53M | 40.61M | -54.90M | -50.38M | 47.21M | -72.73M |
| Free Cash Flow | 549.45M | -814.58M | -159.00M | -136.71M | 139.03M | -163.35M | -141.64M | -124.05M | -126.11M | -154.43M | 33.68M | -111.16M |
This table shows 12 quarterly periods of Ionis Pharmaceuticals's cash flow statement, from Q2 2026 back to Q3 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IONS's reporting calendar. What is a cash flow statement?